A study found that the incidence of endometrial cancer was significantly reduced by taking oral contraceptives (short-acting pills). The longer the duration of the pill, the lower the incidence of endometrial cancer. The study, published in Lancet Oncology, analyzed all available data on the pill and women’s health, and they found that from 1965 to 2014, more than 400,000 women in high-income countries were prevented from developing endometrial cancer by taking oral short-acting contraceptives. And in the last decade alone, oral contraceptives have prevented 200,000 cases of endometrial cancer. The study collected data on 27,276 cases of endometrial cancer in women from 36 studies, from a variety of countries and regions. These data showed that for every five-year increase in duration of contraceptive use, the incidence of endometrial cancer decreased by 25 percent. In some high-income countries, each decade of oral contraceptive use before age 75 reduced the incidence of endometrial cancer from 2.3 cases to 1.3 cases per 100 people taking the pill. The study also found that the amount of estrogen in the pill was more than twice as high in the 1960s as it was in the 1980s, but the reduction in the incidence of endometrial cancer was similar between the two periods of pill use. This suggests that the low levels of hormones were sufficient to reduce the incidence of endometrial cancer. Many young women take short-acting oral contraceptives in their twenties, and this has a significant reduction in the incidence of endometrial cancer,” said Professor Valerie Beral of the University of Oxford in England. It also reduces the incidence of endometrial cancer and other cancers (such as ovarian cancer) during menopause and beyond, which is relatively low. There is concern that these pills may have side effects or even increase the incidence of cancer, but a large body of statistical data suggests the opposite, that these pills reduce the incidence of different types of cancer. Moreover, these oral contraceptives have a long-term effect of reducing the incidence of cancer.” Nearly five decades of medical data provide ample evidence that medium- to long-term use of short-acting contraceptives (composed of sex hormones and analogs) significantly reduces the incidence of endometrial cancer. In addition to this reduced incidence of cancer, short-acting contraceptives have other benefits that are better than condoms, such as being safe to take, having few side effects, and leading to tighter and smoother skin, while also helping to maintain stable periods and reducing the incidence of ectopic pregnancy. It is important to note that the pill mentioned in this study is an oral short-acting contraceptive, the main ingredient of which is estrogen, which can inhibit ovulation, and not the emergency contraceptive pill, which can cause a lot of harm, so please do treat it differently. So, to use the pill carefully is to protect yourself, short-acting contraceptive pills, you deserve.